Pediatrix Medical (MD) Restructuring Costs (2019 - 2026)

Pediatrix Medical (MD) has 8 years of Restructuring Costs data on file, last reported at $4.9 million in Q1 2026.

• Restructuring Costs for Q1 2026 came in at $4.9 million, down 25.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $20.6 million (down 67.0% YoY), and the FY2025 annual result was $22.3 million, down 65.34% from the prior year.
• Restructuring Costs declined to $4.9 million in Q1 2026 per MD's latest filing, from $5.9 million in the prior quarter.
• Over five years, Restructuring Costs peaked at $23.6 million in Q4 2024 and troughed at $977000.0 in Q3 2022.
• A 5-year average of $8.6 million and a median of $5.9 million in 2025 frame the typical range for Restructuring Costs.
• The sharpest annual moves came in 2023 and 2024: Restructuring Costs slumped 88.66% in 2023, then soared 965.39% in 2024.
• A 5-year view of Restructuring Costs shows it stood at $19.6 million in 2022, then tumbled by 88.66% to $2.2 million in 2023, then soared by 965.39% to $23.6 million in 2024, then sank by 75.13% to $5.9 million in 2025, then fell by 16.28% to $4.9 million in 2026.
• Business Quant data shows MD's Restructuring Costs at $4.9 million in Q1 2026, $5.9 million in Q4 2025, and $6.0 million in Q3 2025.